Skip to main content
 This program is not active.
Not Found
On Demand

Update on Anti-Obesity Medications – Nicholas Pennings, DO

Total Credits: .75 including .75 AOA Category 1-A Credit(s)

Average Rating:
State Associations:
NCOMA - North Carolina
Nicholas Pennings
50 Minutes
Never expires.


Update on Anti-Obesity Medications
Learning Objectives

  1.  Recognize the rationale for using anti-obesity medications.
  2.  Utilize FDA approved medications for obesity treatment.
  3.  Identify the role of medications not approved by the FDA in weight management.
  4.  Identify medications under investigation for obesity treatment.

    The North Carolina Osteopathic Medical Association is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians and designates this program for a maximum of .75 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.

Grievance Policy:  The NCOMA strives to provide high quality CME activities by following the current guidelines issued by the American Osteopathic Association (AOA). All grievances should be in writing and should specify the nature of the grievance.  Written grievances must be submitted to the Executive Director of NCOMA for review by e-mail.  Visit the website at for contact info.  Grievances that cannot be resolved will be sent to the AOA Council on CME. 



Nicholas Pennings's Profile

Nicholas Pennings Related seminars and products

Dr. Pennings is Chair of the Family Medicine Department, Associate Professor at the Campbell University School of Osteopathic Medicine and Director of the Campbell University Health Center.  He is a graduate of the Philadelphia College of Osteopathic Medicine and is Board Certified in Family Medicine & Obesity Medicine.  Dr. Pennings is a fellow of the Obesity Medicine Association and an Executive Director of Clinical Education for the OMA.  

Speaker reported serving as an independent contractor for Medifiast; however, the relationship did not present a conflict for this session.



Overall:      4.5

Total Reviews: 2

Please wait ...

Back to Top